Wecare Weizmannia Coagulans Bc99 | Probiotic Strain Manufacturer

Home
Products
Products

We are leaders in microbiome research, with a focus on probiotic strains, starter cultures, and the influence of beneficial microbial communities on diverse hosts, including humans, animals, and plants.
News
News

We actively participate in international probiotic industry seminars and conferences, sharing our research results and industry insights with leading experts and peers around the world.
- Company News
- Industry Insight
About Us
About Us

We are leaders in microbiome research, with a focus on probiotic strains, starter cultures, and the influence of beneficial microbial communities on diverse hosts, including humans, animals, and plants.
Founder
Founder

We actively participate in international probiotic industry seminars and conferences, sharing our research results and industry insights with leading experts and peers around the world.
- Dr. Frank Fang
Contact Us
Contact Us

We welcome the opportunity to connect with you, share more insights, explore potential partnerships, and work together to drive innovation and growth in the probiotic industry.
- Contact Us
- Join Us

English Français Español Русский

Home > Products > WecLac^® Individual Clinical Strains > Weizmannia coagulans

Weizmannia coagulansBC99

Potency

300B CFU/g

Research

10+ Clinical Studies 18+ SCI Papers

Deposit Number

PTA-126829(ATCC) DSM 35066(DSMZ)

No.21801(CGMCC)

Functions

Sports Nutrition
Gastric Health
Gut Health
Weight Management
Liver Health
Immune Health
Emotional Health
Metabolic Health
Oral Health

References

[1] Weizmannia coagulans BC99 Improves Strength Performance by Enhancing Protein Digestion and Regulating Skeletal Muscle Quality in College Students of Physical Education Major. 2024. https://doi.org/10.3390/nu16233990.
[2] A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Weizmannia coagulans BC99 in the treatment of chronic constipation in adults. 2024. https://doi.org/10.3389/fnut.2024.1395083.
[3] Weizmannia coagulans spores alleviates DSS-induced ulcerative colitis model by modulation of gut flora, metabolites and suppressing TLR4/MyD88/NF-κB pathway. 2024. https://doi.org/10.26599/FSHW.2024.9250351
[4] Weizmannia coagulans BC99 affects valeric acid production via regulating gut microbiota to ameliorate inflammation and oxidative stress responses in Helicobacter pylori mice. 2024. https://doi.org/10.1111/1750-3841.17514.
[5] Weizmannia coagulans BC99 Enhances Intestinal Barrier Function by Modulating Butyrate Formation to Alleviate Acute Alcohol Intoxication in Rats. 2024. https://doi.org/10.3390/nu16234142
[6] Weizmannia coagulans BC99 alleviates hyperuricemia and oxidative stress via DAF-16/SKN-1 activation in Caenorhabditis elegan. 2024. https://doi.org/10.3389/fmicb.2024.1498540
[7] Comprehensive genomic analysis and evaluation of in vivo and in vitro safety of Heyndrickxia coagulans BC99. 2024. https://doi.org/10.1038/s41598-024-78202-

Introduction

Gastrointestinal Health

Recent research has highlighted the promising benefits of the BC99 in managing gastric health, specifically in combating H. pylori infections. Mice treated with BC99 after H. pylori infection displayed marked improvements in gastric inflammation, reduced oxidative stress, and healthier gut microbiota composition.